BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19128253)

  • 21. Small leucine-rich proteoglycans in kidney disease.
    Schaefer L
    J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring.
    Honardoust D; Varkey M; Marcoux Y; Shankowsky HA; Tredget EE
    J Burn Care Res; 2012; 33(2):218-27. PubMed ID: 22079916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteoglycan expression is influenced by mechanical load in TMJ discs.
    Nakao Y; Konno-Nagasaka M; Toriya N; Arakawa T; Kashio H; Takuma T; Mizoguchi I
    J Dent Res; 2015 Jan; 94(1):93-100. PubMed ID: 25348543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo.
    Provenzano PP; Alejandro-Osorio AL; Valhmu WB; Jensen KT; Vanderby R
    Matrix Biol; 2005 Jan; 23(8):543-55. PubMed ID: 15694131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of lumican in human lungs.
    Dolhnikoff M; Morin J; Roughley PJ; Ludwig MS
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):582-7. PubMed ID: 9761754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of lumican and fibromodulin following interleukin-1 beta stimulation of disc cells of the human temporomandibular joint.
    Kiga N; Tojyo I; Matsumoto T; Hiraishi Y; Shinohara Y; Makino S; Fujita S
    Eur J Histochem; 2011; 55(2):e11. PubMed ID: 22073367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of interleukin-1beta and dehydroepiandrosterone on the expression of lumican and fibromodulin in fibroblast-like synovial cells of the human temporomandibular joint.
    Okamoto K; Kiga N; Shinohara Y; Tojyo I; Fujita S
    Eur J Histochem; 2015 Feb; 59(1):2440. PubMed ID: 25820556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
    Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
    Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a bioscaffold on collagen fibrillogenesis in healing medial collateral ligament in rabbits.
    Liang R; Woo SL; Nguyen TD; Liu PC; Almarza A
    J Orthop Res; 2008 Aug; 26(8):1098-104. PubMed ID: 18327796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF beta 1 and biglycan, decorin, and fibromodulin metabolism in canine cartilage.
    Burton-Wurster N; Liu W; Matthews GL; Lust G; Roughley PJ; Glant TT; Cs-Szabó G
    Osteoarthritis Cartilage; 2003 Mar; 11(3):167-76. PubMed ID: 12623288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans--biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin.
    Matsushima N; Ohyanagi T; Tanaka T; Kretsinger RH
    Proteins; 2000 Feb; 38(2):210-25. PubMed ID: 10656267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the expression pattern of five genes of the family of small leucine-rich proteoglycans during mouse development.
    Wilda M; Bächner D; Just W; Geerkens C; Kraus P; Vogel W; Hameister H
    J Bone Miner Res; 2000 Nov; 15(11):2187-96. PubMed ID: 11092399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I and Class II small leucine-rich proteoglycans in human cutaneous pacinian corpuscles.
    García-Piqueras J; García-Mesa Y; Feito J; García B; Quiros LM; Martín-Biedma B; Cobo T; Vega JA; García-Suárez O
    Ann Anat; 2019 Jul; 224():62-72. PubMed ID: 31005573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs.
    Brown S; Melrose J; Caterson B; Roughley P; Eisenstein SM; Roberts S
    Eur Spine J; 2012 May; 21 Suppl 2(Suppl 2):S154-9. PubMed ID: 22358337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered levels of extracellular matrix molecule mRNA in healing rabbit ligaments.
    Boykiw R; Sciore P; Reno C; Marchuk L; Frank CB; Hart DA
    Matrix Biol; 1998 Oct; 17(5):371-8. PubMed ID: 9822203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential MMP-14 targeting by biglycan, decorin, fibromodulin, and lumican unraveled by in silico approach.
    Rivet R; Rao RM; Nizet P; Belloy N; Huber L; Dauchez M; Ramont L; Baud S; Brézillon S
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C353-C365. PubMed ID: 36534501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteoglycans and Diseases of Soft Tissues.
    Hwang CT; Halper J
    Adv Exp Med Biol; 2021; 1348():127-138. PubMed ID: 34807417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.
    Westergren-Thorsson G; Hernnäs J; Särnstrand B; Oldberg A; Heinegård D; Malmström A
    J Clin Invest; 1993 Aug; 92(2):632-7. PubMed ID: 7688761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-beta in the human cervix during pregnancy and involution.
    Westergren-Thorsson G; Norman M; Björnsson S; Endrésen U; Stjernholm Y; Ekman G; Malmström A
    Biochim Biophys Acta; 1998 Mar; 1406(2):203-13. PubMed ID: 9573366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.
    Hultgårdh-Nilsson A; Borén J; Chakravarti S
    J Intern Med; 2015 Nov; 278(5):447-61. PubMed ID: 26477596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.